Prestige Consumer Healthcare Inc.

PBH · NYSE

Price$0.00+0.00 (+0.00%)

Price History

Volume & Moving Averages

Price50D200D

Analyst Price Target

$0.00▲ 0.0% above current price

Range: $0.00 – $0.00 · 0 analysts

Based on Wall Street analyst estimates — not a Stockinder prediction.

About the company

Jarvis is thinking

Key Metrics

Report card

Open as standalone page ↗

Jarvis is thinking

Recent Notable Coverage

Jarvis is thinking

Report Card

Growth

Health

Risk

Value

Quality

Ownership

Insider and institutional holdings, from Yahoo Finance — for Indian companies this roughly tracks promoter (insiders) and combined FII/DII (institutions) stakes, though not split out the same way a shareholding-pattern filing would.

Insiders1.4%

Institutions116.3%

Public / Other

Income Statement

	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31	2021-03-31	2020-03-31	2019-03-31	2018-03-31	2017-03-31
Total money the company brought in from its core business during the period, before any costs are subtracted.	$1.09B	$1.14B	$1.13B	$1.13B	$1.09B	$943.37M	$963.01M	$975.78M	$387000	$947000
The direct costs of producing what was sold — raw materials, manufacturing, direct labor.	$10.33M	$8.88M	$8.12M	$7.55M	$7.22M	$6.22M	$4.23M	$4.73M	$464.67M	–
Revenue left after subtracting the direct cost of producing goods or services — how efficiently the core business converts sales into profit before overhead.	$595.58M	$634.46M	$624.45M	$625.29M	$620.65M	$547.47M	$552.22M	$555.58M	$576.50M	$500.29M
Gross profit as a percentage of revenue.	54.7%	55.8%	55.5%	55.4%	57.1%	58.0%	57.3%	56.9%	148967.7%	52828.5%
Profit from core operations after subtracting the cost of revenue and operating expenses like R&D and marketing, but before interest and taxes.	$309.41M	$336.77M	$342.43M	-$22.41M	$329.92M	$297.40M	$291.15M	$67.50M	$215.87M	$205.61M
Operating income as a percentage of revenue.	28.4%	29.6%	30.4%	-2.0%	30.4%	31.5%	30.2%	6.9%	55779.3%	21712.0%
The company's bottom-line profit after all expenses, interest, and taxes are subtracted.	$190.30M	$214.60M	$209.34M	-$82.31M	$205.38M	$164.68M	$142.28M	-$35.80M	$339.57M	$69.39M
Net income divided by the number of shares outstanding — profit attributable to each share.	$3.93	$4.32	$4.21	$-1.65	$4.09	$3.28	$2.81	$-0.69	$6.00	$1.00
Like basic EPS, but accounts for shares that could be created from stock options or convertible securities — a more conservative per-share profit figure.	$3.91	$4.29	$4.17	$-1.65	$4.04	$3.25	$2.78	$-0.69	$6.00	$1.00

Balance Sheet

	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31	2021-03-31	2020-03-31	2019-03-31	2018-03-31	2017-03-31
Cash and highly liquid short-term investments the company can access almost immediately.	$63.87M	$97.88M	$46.47M	$58.49M	$27.18M	$32.30M	$94.76M	$27.53M	$32.55M	$41.85M
Everything the company owns that has value — cash, property, inventory, investments, and more.	$3.49B	$3.40B	$3.32B	$3.35B	$3.67B	$3.43B	$3.51B	–	$3.76B	$3.91B
All of the company's interest-bearing borrowings, short and long term combined.	–	–	$1.13B	$1.35B	$1.48B	$1.48B	$1.73B	$1.80B	$1.99B	$2.19B
Everything the company owes — debt, unpaid bills, and other obligations.	$1.61B	$1.57B	$1.66B	$1.91B	$2.09B	$2.07B	$2.34B	–	$2.58B	$3.09B
What would be left for shareholders if the company sold all its assets and paid off all its debts — total assets minus total liabilities.	$1.89B	$1.83B	$1.66B	$1.45B	$1.58B	$1.36B	$1.17B	–	$1.18B	$822.55M

Cash Flow Statement

	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31	2021-03-31	2020-03-31	2019-03-31	2018-03-31	2017-03-31
Actual cash generated by the core business, as opposed to accounting profit, which can include non-cash items.	$257.63M	$251.51M	$248.93M	$229.72M	$259.92M	$235.61M	$217.12M	$189.28M	$210.11M	$147.77M
Cash spent on physical assets like property, equipment, and infrastructure to maintain or grow the business.	$11.18M	$8.22M	$9.55M	$7.78M	$9.64M	$22.24M	$14.56M	$10.48M	$12.53M	$2.98M
Cash left over after capital expenditures — money the company could use for dividends, buybacks, debt repayment, or reinvestment.	$246.45M	$243.29M	$239.38M	$221.93M	$250.28M	$213.36M	$202.56M	$178.80M	$197.58M	$144.79M

	You	Peer avg
P/E	14.6	–
Revenue Growth	+6.5%	+63.9%
ROE	9.1%	-126.6%

Prestige Consumer Healthcare Inc.

Price History

Volume & Moving Averages

Analyst Price Target

About the company

Key Metrics

Report card

Jarvis Analysis

Recent Notable Coverage

Report Card

Ownership

Quick Actions

Reports & Coverage

Con Call Reports

Board of Directors / Annual Reports

Recent Articles

Income Statement

Balance Sheet

Cash Flow Statement

Peer Comparison